Summary:
Synergy Laboratories has introduced the FDA-cleared Genius Digital Diagnostics System with AI-driven cervical cancer screening, enhancing diagnostic precision and accessibility in the Southeast.

Takeaways:

  1. Advanced AI Integration: The system combines deep-learning AI with volumetric imaging to improve cervical cancer detection.
  2. Improved Accessibility: Digital cytology enables remote collaboration and faster diagnostics, benefiting underserved areas.
  3. Future Innovation: Continued AI advancements may enhance predictive accuracy and early detection of cervical and other cancers.

Synergy Laboratories, a full-service diagnostic laboratory, has launched Hologic’s state-of-the-art Genius Digital Diagnostics System with Genius Cervical AI algorithm marking a significant advancement in cervical cancer screening and diagnostics. Synergy Laboratories is setting a new benchmark for precision medicine, enhancing diagnostic detection and efficiency for healthcare providers across the Southeast, according to the company.

Superpowering Cervical Cancer Screening

Through a strategic collaboration with Hologic, Inc., Synergy Laboratories is, bringing the FDA-cleared digital cytology system to Alabama and the Gulf Coast. The Genius Digital Diagnostics System, which received U.S. Food and Drug Administration (FDA) clearance in 2024, integrates deep-learning-based AI with volumetric imaging technology to improve the detection of precancerous lesions and cervical cancer cells.

“Our commitment to advancing women’s healthcare through cutting-edge technology is exemplified by the introduction of this AI-powered platform,” says Brad Pitts, CEO of Synergy Laboratories. “This innovation empowers physicians with highly accurate diagnostic insights, ultimately enhancing patient care and treatment outcomes.”

Enhancing Diagnostic Accuracy and Access to Car

According to Tyler Jones, MD, Medical Director at Synergy Laboratories, the deployment of digital cytology significantly expands access to high-quality diagnostic services, particularly in underserved or rural areas where specialized pathology expertise may be limited. 

“With this platform, the laboratory can digitally image, store, review, and collaborate securely on high-resolution cytology images with remote pathologists, expediting diagnostic turnaround times and improving access to expert interpretation,” he says.

This launch represents just the beginning of Synergy Laboratories’ broader commitment to AI-driven innovation in diagnostic medicine. Increased data collection and algorithmic learning will enhance the system’s predictive accuracy, potentially identifying novel early detection markers and refining treatment strategies for cervical and other cancers, according to the company.

Featured Image: Designer491 | Dreamstime.com